14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $11.01 $14.21 Friday, 3rd May 2024 IOVA stock ended at $13.63. This is 5.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $13.30 to a day high of $13.88.
90 days $7.62 $18.33
52 weeks $3.21 $18.33

Historical Iovance Biotherapeutics, Inc. prices

Date Open High Low Close Volume
Jan 17, 2024 $8.19 $8.20 $7.49 $8.04 9 501 063
Jan 16, 2024 $8.88 $8.91 $8.29 $8.37 5 687 415
Jan 12, 2024 $9.13 $9.60 $8.91 $9.01 3 807 638
Jan 11, 2024 $9.19 $9.35 $8.88 $9.15 6 131 394
Jan 10, 2024 $9.95 $10.00 $9.27 $9.35 9 909 948
Jan 09, 2024 $9.34 $10.31 $9.28 $9.91 11 416 375
Jan 08, 2024 $8.38 $9.57 $8.16 $9.56 9 540 629
Jan 05, 2024 $7.95 $8.56 $7.69 $8.47 7 416 995
Jan 04, 2024 $7.95 $8.25 $7.88 $8.11 5 304 329
Jan 03, 2024 $8.04 $8.16 $7.75 $7.90 5 666 387
Jan 02, 2024 $7.98 $8.38 $7.87 $8.10 6 742 996
Dec 29, 2023 $8.60 $8.73 $8.09 $8.13 10 173 086
Dec 28, 2023 $7.54 $8.59 $7.33 $8.58 18 003 154
Dec 27, 2023 $7.06 $7.37 $6.70 $7.23 31 203 700
Dec 26, 2023 $8.53 $9.03 $8.45 $8.89 7 112 773
Dec 22, 2023 $7.97 $8.80 $7.97 $8.34 9 303 538
Dec 21, 2023 $7.32 $8.00 $7.32 $7.89 7 105 378
Dec 20, 2023 $7.80 $7.82 $6.75 $7.18 10 444 518
Dec 19, 2023 $7.95 $8.02 $7.75 $7.82 5 250 938
Dec 18, 2023 $7.75 $7.93 $7.45 $7.85 5 074 265
Dec 15, 2023 $7.80 $8.50 $7.59 $7.78 13 189 940
Dec 14, 2023 $7.39 $7.80 $7.33 $7.71 10 500 094
Dec 13, 2023 $6.40 $7.37 $6.38 $7.35 10 958 351
Dec 12, 2023 $6.23 $6.47 $6.00 $6.39 5 734 920
Dec 11, 2023 $6.35 $6.37 $6.02 $6.25 5 417 493
Click to get the best stock tips daily for free!

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers... IOVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT